Abstract:To fully develop its potential boron neutron capture therapy (BNCT) requires the combination of a suitable thermal/epithermal neutron flux together with a selective intake of (10)B-boron nuclei in the target tissue. The latter condition is the most critical to be realized as none of the boron carriers used for experimental or clinical purposes proved at the moment an optimal selectivity for cancer cells compared to normal cells. In addition to complex physical factors, the assessment of the intracellular concentration of boron represent a crucial parameter to predict the dose delivered to the cancer cells during the treatment. Nowadays the dosimetry calculation and then the prediction of the treatment effectiveness are made using Monte Carlo simulations, but some of the model assumption are still uncertain: the radiobiological dose efficacy and the probability of tumour cell survival are crucial parameters that needs a more reliable experimental approach. The aim of this work was to evaluate the differential ability of two cell lines to selectively concentrate the boron-10 administered as di-hydroxyboryl-phenylalanine (BPA)-fructose adduct, and the effect of the differential boron intake on the damage produced by the irradiation with thermal neutrons; the two cell lines were selected to be representative one of normal tissues involved in the active/passive transport of boron carriers, and one of the tumour. Recent in vitro studies demonstrated how BPA is taken by proliferating cells, however the mechanism of BPA uptake and the parameters driving the kinetics of influx and the elimination of BPA are still not clarified. In these preliminary studies we analysed the survival of F98 and human umbilical vein endothelial cells (HUVEC) cells line after irradiation, using different thermal fluencies at the same level of density population and boron concentration in the growing medium prior the irradiation. This is first study performed on endothelium model obtained by a primary human cell line (HUVEC). The perspective application of this work is to develop a model able to foresee the effects produced by different combination of boron influx with a thermal neutron fluencies, applying a standardized radiobiological methodology, and in particular to continue the investigation of the radiobiological effects on the endothelium model as the main tissue involved in the transport of boronated molecules.

Irradiation facility at the TRIGA Mainz for treatment of liver metastases

[The preliminary report of a registration clinical trial of proton and heavy ion irradiation].

Confirmation of a realistic reactor model for BNCT dosimetry at the TRIGA Mainz

Dose determination using alanine detectors in a mixed neutron and gamma field for boron neutron capture therapy of liver malignancies

Organization and operation of multi particle therapy facilities: the Marburg Ion-Beam Therapy Center, Germany (MIT)

Technical and dosimetric realization of in vivo x-ray microbeam irradiations at the Munich Compact Light Source

A proof of principle experiment for microbeam radiation therapy at the Munich compact light source

In Vivo Microbeam Radiation Therapy at a Conventional Small Animal Irradiator

Beam Energy Considerations for Gold Nano-Particle Enhanced Radiation Treatment

Depth dose measurements in water for 11C and 10C beams with therapy relevant energies

Concept and performance evaluation of two 3 GHz buncher units optimizing the dose rate of a novel preclinical proton minibeam irradiation facility

Radiation protection aspects in the design of a Boron Neutron Capture Therapy irradiation room

New developments for theranostic radioisotope production with solid targets at the Bern medical cyclotron

Imaging with protons at MedAustron

Dosimetric verification in water of a Monte Carlo treatment planning tool for proton, helium, carbon and oxygen ion beams at the Heidelberg Ion Beam Therapy Center

A facility for radiation hardness studies based on a medical cyclotron

In vitro neutron irradiation of glioma and endothelial cultured cells

Clinical microbeam radiation therapy with a compact source: specifications of the line-focus X-ray tube

Radiobiology with cyclotron proton beams: A viability study

Design development and implementation of an irradiation station at the neutron time-of-flight facility at CERN

Design of the 590 MeV proton beamline for the proposed TATTOOS isotope production target at PSI